Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

被引:42
|
作者
Esquirol, Albert [1 ]
Pascual, Maria Jesus [2 ]
Kwon, Mi [3 ]
Perez, Ariadna [4 ]
Parody, Rocio [5 ]
Ferra, Christelle [6 ]
Garcia Cadenas, Irene [1 ]
Herruzo, Beatriz [2 ]
Dorado, Nieves [3 ]
Hernani, Rafael [4 ]
Sanchez-Ortega, Isabel [5 ]
Torrent, Anna [6 ]
Sierra, Jorge [1 ]
Martino, Rodrigo [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, IIB St Pau & Jose Carreras Leukemia Res Inst, Hematol Dept, Barcelona, Spain
[2] Hosp Reg Univ, Hematol Dept, Malaga, Spain
[3] Hosp Gregorio Maranon, Hematol Dept, Madrid, Spain
[4] Hosp Clin Univ, Hematol Dept, Madrid, Spain
[5] Bellvitge Hosp, Hematol Dept, Barcelona, Spain
[6] Hosp Badalona Germans Trias & Pujol, Hematol Dept, Badalona, Spain
关键词
BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CYCLOPHOSPHAMIDE; RISK-FACTORS; HEMATOLOGIC MALIGNANCIES; HEMORRHAGIC CYSTITIS; ACUTE-LEUKEMIA; BACTEREMIA; OUTCOMES; DONORS; ADULTS;
D O I
10.1038/s41409-021-01328-4
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy. The median follow-up for survivors was 37 months. The overall incidence of bloodstream infections by gram-positive and gram-negative bacteria at 37 months was 51% and 46%, respectively. The incidence of cytomegalovirus infection was 69%, while Epstein Barr virus infections occurred in 10% of patients and hemorrhagic cystitis in 35% of cases. Invasive fungal infections occurred in 11% at 17 months. The 3-year incidence of infection-related mortality was 19%. The median interval from transplant to IRM was 3 months (range 1-30), 53% of IRM occurred >100 days post-haploSCT. Risk factors for IRM included age >50 years, lymphoid malignancy, and developing grade III-IV acute GvHD. Bacterial infections were the most common causes of IRM (51%), mainly due to gram-negative bacilli BSI. In conclusion, severe infections are the most common causes of NRM after haploSCT with PTCy, with a reemergence of gram-negative bacilli as the most lethal pathogens. More studies focusing on the severe infections after haploSCT with PTCy and differences with other types of alloSCT in adults are clearly warranted.
引用
收藏
页码:2432 / 2444
页数:13
相关论文
共 50 条
  • [21] Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases
    Ehud Even-Or
    Adeeb NaserEddin
    Yael Dinur Schejter
    Bella Shadur
    Irina Zaidman
    Polina Stepensky
    [J]. Bone Marrow Transplantation, 2021, 56 : 434 - 441
  • [22] Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases
    Even-Or, Ehud
    NaserEddin, Adeeb
    Dinur Schejter, Yael
    Shadur, Bella
    Zaidman, Irina
    Stepensky, Polina
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (02) : 434 - 441
  • [23] Experience on Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Children With Hematological Malignancies
    Tsujimoto, Shinichi
    Osumi, Tomoo
    Sakamoto, Kenichi
    Isshiki, Kyohei
    Mizuno, Takanori
    Uchiyama, Meri
    Sugawa, Masahiro
    Matsukawa, Yukihiro
    Shioda, Yoko
    Kiyotani, Chikako
    Terashima, Keita
    Uchiyama, Toru
    Deguchi, Takao
    Tomizawa, Daisuke
    Kato, Motohiro
    Matsumoto, Kimikazu
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S93 - S93
  • [24] Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
    Ignacio Gómez-Centurión
    Reyes Maria Martin Rojas
    Rebeca Bailén
    Cristina Muñoz
    Santiago Sabell
    Gillen Oarbeascoa
    Paula Fernández-Caldas
    Diego Carbonell
    Jorge Gayoso
    Carolina Martínez-Laperche
    Ismael Buño
    Javier Anguita
    José Luis Díez-Martin
    Mi Kwon
    [J]. Annals of Hematology, 2023, 102 : 1561 - 1567
  • [25] Outcomes of Haploidentical Salvage Transplantation Using Post-Transplant Cyclophosphamide for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation
    Harada, Kaito
    Fuji, Shigeo
    Najima, Yuho
    Kato, Motohiro
    Shinohara, Akihito
    Toyosaki, Masako
    Nakamae, Hirohisa
    Hasegawa, Daisuke
    Iida, Hiroatsu
    Onizuka, Makoto
    Hashii, Yoshiko
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Nakasone, Hideki
    [J]. BLOOD, 2021, 138
  • [26] GVHD PROPHYLAXIS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Storti, G.
    Santoro, L.
    Marano, L.
    De Santis, G.
    Manfra, I.
    Urciuoli, E.
    Marotta, S.
    Frieri, C.
    Cacace, F.
    Pagliuca, S.
    Serio, B.
    D'Addona, M.
    Giudice, V.
    Guariglia, R.
    Palmieri, F.
    Selleri, C.
    Cantore, N.
    Risitano, A. M.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 179 - 180
  • [27] Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide
    A Unnikrishnan
    S C Glover
    O Norkina
    J R Wingard
    M Norkin
    [J]. Bone Marrow Transplantation, 2017, 52 : 1204 - 1205
  • [28] Unmanipulated haploidentical hematopoietic stem cells transplantation (HaploSCT) with post-transplant cyclophosphamide: Experience of the hematology and stem cell transplant center of Pesaro, Italy
    Giardini, C.
    Barulli, S.
    Guiducci, B.
    Leopardi, G.
    Malerba, L.
    Isidori, A.
    Clissa, C.
    Parolini, M.
    Sparaventi, G.
    Nicolini, G.
    Dadamo, F.
    Stramigioli, S.
    Talevi, N.
    Valentini, M.
    Nesci, S.
    Visani, G.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S514 - S515
  • [29] Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide
    Unnikrishnan, A.
    Glover, S. C.
    Norkina, O.
    Wingard, J. R.
    Norkin, M.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 (08) : 1204 - 1205
  • [30] Autoimmune Limbic Encephalitis in Patients with Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Heo, Bu Yeon
    Lee, Myung-Won
    Choi, Suyoung
    Jung, Yunju
    Pham, Thi Thuy Duong
    Jang, Yunseon
    Park, Jung-Hyun
    Kang, Sora
    Koh, Jeong Suk
    Jo, Deog-Yeon
    Kwon, Jaeyul
    Song, Ik-Chan
    [J]. CELLS, 2023, 12 (16)